Loading TMQ…
Loading financial statements…
Import this data to Google Sheets with:
=jivedata("TMQ","financials")Full statements spill as a table. For one cell: =jivedata("TMQ","Revenue") or =jivedata("TMQ","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.
TMQ • CIK 0001543418
| (in thousands, except per share data) | FY 2023 | FY 2024 | FY 2025 |
|---|
| (in thousands, except per share data) | FY 2023 | FY 2024 | FY 2025 | TTM |
|---|---|---|---|---|
| Cash and Cash Equivalents, at Carrying Value | — | $25,834 | $51,613 | $31,209 |
| Accounts Receivable, after Allowance for Credit Loss, Current | $33 | $16 | $118 | $93 |
| Equity Method Investments | $135,021 | $107,497 | $105,263 | $109,029 |
| Prepaid Expense, Current | $259 | $195 | $193 | $338 |
| Operating Lease, Right-of-Use Asset | $113 | $155 | $117 | $85 |
| Assets, Current | $2,882 | $26,045 | $51,924 | $31,640 |
| Assets | $138,020 | $133,697 | $157,304 | $140,754 |
| Liabilities | $465 | $903 | $33,183 | $23,912 |
| Common Stock, Value, Issued | $187,886 | $190,503 | $225,241 | $228,105 |
| Additional Paid in Capital | $28,237 | $28,801 | $27,294 | $30,359 |
| Retained Earnings (Accumulated Deficit) | $-81,813 | $-90,400 | $-132,641 | $-145,805 |
| Stockholders' Equity Attributable to Parent | $137,555 | $132,794 | $124,121 | $116,842 |
| Accounts Payable and Accrued Liabilities, Current | $432 | $756 | $2,329 | $861 |
| Operating Lease, Liability, Current | $33 | $37 | $41 | $45 |
| Derivative Liability, Current | — | — | $30,743 | $22,970 |
| Liabilities, Current | $465 | $793 | $33,113 | $23,876 |
| Operating Lease, Liability, Noncurrent | $33 | $110 | $70 | $36 |
| Common Stock, Shares, Issued | 155,925,990 | 161,085,313 | 171,069,888 | 172,945,639 |
| (in thousands, except per share data) | FY 2023 | FY 2024 | FY 2025 | TTM |
|---|---|---|---|---|
| Net Income (Loss) Attributable to Parent | $-14,951 | $-8,587 | $-42,241 | $-47,858 |
| Net Cash Provided by (Used in) Operating Activities | $-3,093 | $-1,828 | $-3,248 | $-5,452 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect | $22 | $23,246 | $25,762 | $7,774 |
| Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | $-5 | $-2 | $17 | $63 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | $2,590 | $25,834 | $51,613 | $74,184 |
| Amortization | $8 | $4 | $4 | $4 |
| Sale of Stock, Consideration Received on Transaction | — | — | $24,325 | $24,325 |
| Restricted Stock or Unit Expense | $116 | $120 | $30 | $30 |
| Proceeds from Stock Options Exercised | $54 | $74 | $5,685 | $5,737 |
| Net Cash Provided by (Used in) Financing Activities | $3,115 | $74 | $30,010 | $31,226 |
| Income (Loss) from Equity Method Investments | $-7,844 | $-2,636 | $-11,392 | $-22,390 |
| Foreign Currency Transaction Gain (Loss), Unrealized | $-5 | $2 | $17 | $63 |
| Share-based Payment Arrangement, Expense | $3,887 | $3,520 | $3,336 | $4,810 |
| Increase (Decrease) in Accounts Receivable | $-7 | $-17 | $-8 | $-34 |
| Proceeds from Equity Method Investment, Distribution, Return of Capital | — | $25,000 | $25,000 | $25,000 |
| Increase (Decrease) in Prepaid Expense | $-61 | $-64 | $-2 | $-6 |
| Payments to Acquire Equity Method Investments | — | — | $1,000 | $1,000 |
| Increase (Decrease) in Accounts Payable and Accrued Liabilities | $-64 | $324 | $1,655 | $417 |
| Net Cash Provided by (Used in) Investing Activities | $142 | $25,000 | $-1,000 | $-1,000 |